Clinical Trials Browser

Extensive Stage Lung Small Cell Carcinoma

Adenocarcinoma of Lung, Lung Neoplasms

Nasopharyngeal Carcinoma

Burkitt Lymphoma

Neuroblastoma, Ganglioneuroblastoma

Oropharyngeal Neoplasms

Urinary Bladder Neoplasms

Sinonasal Squamous Cell Carcinoma

Glioblastoma, Gliosarcoma

Esophageal Neoplasms

Carcinoma, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Rectal Neoplasms

Esophageal Squamous Cell Carcinoma

Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Oropharyngeal Neoplasms

Carcinoma, Non-Small-Cell Lung

Urinary Bladder Neoplasms

Glioblastoma, Gliosarcoma

Breast Neoplasms

Brain Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Carcinoma, Non-Small-Cell Lung

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Sarcoma, Ewing

Carcinoma, Non-Small-Cell Lung

Meningeal Carcinomatosis

Prostatic Neoplasms

Breast Neoplasms, Neoplasms

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Neoplasm Metastasis, Neoplasms

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Biphenotypic, Acute

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Rhabdomyosarcoma, Embryonal

Medulloblastoma

Lung Neoplasms, Small Cell Lung Carcinoma

Glioblastoma

Pancreatic Neoplasms

Squamous Cell Carcinoma of Head and Neck

Clinical Trials

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial

ANCRE

Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer

REDUCE-30

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

MINT-2

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

A Study of Surgery and Radiotherapy in People With Breast Cancer

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma

CONVERGE

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

HOPE

BEAR

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Safety and Efficacy of Whole Brain LDRT+ICI+Intrathecal Chemotherapy in Refractory Meningeal Metastasis of Lung Cancer

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast

OMEC-5

Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer

Intra- and Inter-fraction Changes in Radiation Therapy

Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

UNC Metastatic Cancer Radiation Therapy Registry

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

G-CSF After Chemo-radiation in Patients With Glioblastoma

LAP100

A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.